Profil
Matthew Foster is currently the Chief Restructuring Officer at Allena Pharmaceuticals, Inc. since 2022.
Prior to this, he held the position of Chief Restructuring Officer at Argos Therapeutics, Inc.
Aktive Positionen von Matthew Foster
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02.09.2022 |
Ehemalige bekannte Positionen von Matthew Foster
| Unternehmen | Position | Ende |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
